Cargando…

Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Lakhotia, Rahul, Dunleavy, Kieron, Abramson, Jeremy S., Link, Brian K., Powell, Bayard L., Melani, Christopher, Lucas, Andrea N., Steinberg, Seth M., Friedberg, Jonathan W., Kahl, Brad S., Little, Richard F., Bartlett, Nancy L., Noy, Ariela, Wilson, Wyndham H., Roschewski, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506053/ https://www.ncbi.nlm.nih.gov/pubmed/37389844 http://dx.doi.org/10.1182/bloodadvances.2023010223

Ejemplares similares

End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making
por: Melani, Christopher, et al.
Publicado: (2018)

Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma
por: Lakhotia, Rahul, et al.
Publicado: (2022)

Good outcome of AIDS-related Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) with abbreviated cycles of EPOCH-rituximab
por: Dunleavy, K, et al.
Publicado: (2009)

Be mindful of the central nervous system in Burkitt lymphoma
por: Roschewski, Mark
Publicado: (2021)

Next-generation sequencing–based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCL
por: Miljkovic, Milos D., et al.
Publicado: (2021)

Phase I / II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma
por: Ratner, Lee, et al.
Publicado: (2015)

American epoch : a history of the United States since the 1890's /
por: Link, Arthur S. (Arthur Stanley), 1920-1998
Publicado: (1963)

Doxorubicin pharmacokinetics and toxicity in patients with aggressive lymphoma and hepatic impairment
por: Lai, Catherine, et al.
Publicado: (2022)

Primary Effusion Lymphoma: Is Dose-Adjusted-EPOCH Worthwhile Therapy?
por: Jessamy, Kegan, et al.
Publicado: (2016)

Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma
por: Ratner, L, et al.
Publicado: (2016)

Pooled analysis of AIDS Malignancy Consortium (AMC) trials evaluating rituximab plus either CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin’s lymphoma
por: Barta, Stefan K, et al.
Publicado: (2010)

Successful Use of EPOCH-R in 2 Young Adult Patients With Burkitt Lymphoma and Acute Kidney Injury: A Case Report
por: Ross, Savannah, et al.
Publicado: (2019)

Phase 1b/2 study of ibrutinib and lenalidomide with dose-adjusted EPOCH-R in patients with relapsed/refractory diffuse large B-cell lymphoma
por: Wilson, Wyndham H., et al.
Publicado: (2021)

The cubist epoch
por: Cooper, Douglas, 1911-1984
Publicado: (1970)

The Psychology of Epochs
Publicado: (1852)

Modified dose intensive R- CODOX-M/IVAC for HIV-associated burkitt (BL) (AMC 048) shows efficacy and tolerability, and predictive potential of IRF4/MUM1 expression
por: Noy, Ariela, et al.
Publicado: (2012)

Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin’s Lymphoma (AMC-075)
por: Ramos, Juan C., et al.
Publicado: (2018)

Mengelberg and the symphonic epoch
por: Sollitt, Edna Richolson
Publicado: (1929)

Epochs in the History of Obstetrics
por: Greer, H. L. H.
Publicado: (1935)

The epochs of international law
por: Grewe, Wilhelm G, et al.
Publicado: (2000)

Physicists: epoch and personalities
por: Feinberg, E L, et al.
Publicado: (2011)

The New Epoch in Medicine
por: Ormiston, Robert
Publicado: (1889)

An Epoch in Medical History
Publicado: (1892)

Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in human immunodeficiency virus-associated, B-cell non-Hodgkin lymphoma
por: Sparano, Joseph A., et al.
Publicado: (2020)

P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES
por: Vassilakopoulos, T., et al.
Publicado: (2022)

P1178: THE APPLICABILITY OF PROGNOSTIC MODELS UNDER RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): A COMPARISON WITH R-CHOP
por: Vassilakopoulos, Theodoros, et al.
Publicado: (2023)

An Important Epoch in Medical Education
Publicado: (1914)

Some Personalities of the Hunterian Epoch
por: Woolf, A. E. Mortimer
Publicado: (1929)

Dental Epochs in the Nineteenth Century
Publicado: (1900)

Lateral entorhinal cortex subpopulations represent experiential epochs surrounding reward
por: Issa, John B., et al.
Publicado: (2023)

Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma
por: Thomas, Nicole, et al.
Publicado: (2023)

The first reported case of vincristine‐induced unilateral vocal cord palsy in an adult patient with HIV‐associated Burkitt‐like lymphoma being treated with dose‐escalated R‐EPOCH
por: Rahmat, Leena T., et al.
Publicado: (2018)

Current directions in the treatment of classical Hodgkin lymphoma
por: Keller, Frank G., et al.
Publicado: (2023)

Dose-adjusted EPOCH-R in patients with newly diagnosed diffuse large B-cell lymphoma harboring MYC rearrangement
por: Kojima, Minoru, et al.
Publicado: (2020)

Optimizing Dose-Adjusted EPOCH Chemotherapy with Long-Acting Granulocyte Colony-Stimulating Factor During the COVID-19 Epidemic
por: Wei, Chong, et al.
Publicado: (2021)

Heavy ion therapy: Bevalac epoch
por: Castro, J R
Publicado: (1993)

Morgagni to Virchow: An Epoch in the History of Medicine
por: Steven, John Lindsay
Publicado: (1905)

Safeguarding LGBTQ+ lives in an epoch of abandonment
por: Rosa, William E, et al.
Publicado: (2023)

Harnessing Noxa demethylation to overcome Bortezomib resistance in mantle cell lymphoma
por: Leshchenko, Violetta V., et al.
Publicado: (2015)

P1230: PET/CT IMAGING FOR RESPONSE ASSESSMENT AND TREATMENT GUIDANCE AFTER RITUXIMAB-DOSE-ADJUSTED-EPOCH(R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL):THE GREEK EXPERIENCE ON 107 PATIENTS
por: Vassilakopoulos, T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_usp7pnpcd5e539pujmvaob51nr